InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Reed Joshua, 首席财务官. Officer active across 2 companies, notably Aldeyra Therapeutics, Inc.. Aggregated, 6 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €272k. History available since 30 March 2022. The latest transaction was disclosed on 1 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Reed Joshua is Chief Financial Officer and there are six filings in total associated with him. The sampled recent filings, from 2022-04-01 to 2026-07-06, show sell transactions totaling EUR 272019, mainly in Scholar Rock Holding Corp, with activity also in Aldeyra Therapeutics, Inc.